RXST
RxSight, Inc.Healthcare · $193M market cap
Verdict
We can't put a fair value on RXST right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow RXST
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Aug 31, 2026: no open-market purchases, 4 sales worth $118K and 34 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Weinberg Eric
See remarks · 2026-09-02
Sold
$14K
Goldshleger Ilya
Chief Operating Officer · 2026-09-02
Sold
$14K
Wilterding Mark
Chief Financial Officer · 2026-09-02
Sold
$54K
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-02
Sold
$35K
Other filings
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
Award
$599K
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
Award
$206K
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
Award
$379K
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
Award
$665K
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
Award
$471K
Show all 34 other filingsShow fewer
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
D-Return
$3.5M
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
D-Return
$2.3M
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
D-Return
$5.2M
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
D-Return
$1.8M
Goldshleger Ilya
Chief Operating Officer · 2026-09-05
D-Return
$1.6M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
Award
$1.0M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
Award
$613K
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
Award
$1.1M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
Award
$1.6M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
D-Return
$6.1M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
D-Return
$8.4M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
D-Return
$3.0M
Kurtz Ronald M MD
Chief Medical Officer · 2026-09-05
D-Return
$5.4M
Weinberg Eric
See remarks · 2026-09-05
Award
$599K
Weinberg Eric
See remarks · 2026-09-05
Award
$206K
Weinberg Eric
See remarks · 2026-09-05
Award
$379K
Weinberg Eric
See remarks · 2026-09-05
Award
$527K
Weinberg Eric
See remarks · 2026-09-05
Award
$419K
Weinberg Eric
See remarks · 2026-09-05
D-Return
$3.5M
Weinberg Eric
See remarks · 2026-09-05
D-Return
$2.3M
Weinberg Eric
See remarks · 2026-09-05
D-Return
$5.2M
Weinberg Eric
See remarks · 2026-09-05
D-Return
$1.4M
Weinberg Eric
See remarks · 2026-09-05
D-Return
$1.4M
Wilterding Mark
Chief Financial Officer · 2026-09-05
Award
$1.6M
Wilterding Mark
Chief Financial Officer · 2026-09-05
D-Return
$2.6M
Weinberg Eric
See remarks · 2026-08-31
Option exercise
5,370 shares
Goldshleger Ilya
Chief Operating Officer · 2026-08-31
Option exercise
5,370 shares
Wilterding Mark
Chief Financial Officer · 2026-08-31
Option exercise
20,441 shares
Kurtz Ronald M MD
Chief Medical Officer · 2026-08-31
Option exercise
13,425 shares
About RxSight, Inc.
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works